The CHMP gives a positive opinion to Eli Lilly's Jaypirca in patients with relapsed or refractory CLL in a post-BTK inhibitor setting.

Following a flurry of activity at this month’s meeting of the European Medicines Agency’s Committee for Medicinal Products ...

Surge Copper Corp. ("Surge" or the "Company") announces the grant of equity-based incentive awards under its Share Compensation Plan. The Company has awarded 4,583,334 restricted share units (RSUs) to ...

Eli Lilly said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its Jaypirca cancer drug in certain patients with chronic lymphocytic ...

The Board of Directors of MVB Financial Corp. ("MVBF" or "MVB Financial") has announced the appointment of Vic Maculaitis as a Member of the Board. "With more than 20 years of professional experience ...

Eli Lilly (LLY) and Company announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive ...